Delivery Order SPE2DB20D3103-SPE2DB23FN1V6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Cetirizine HCL 1 mg/ml solution, a pharmaceutical product, with a ceiling value of $8,881.46 and a completion date of April 26, 2024. The award was made on April 25, 2024 under a firm fixed-price contract type. The contract does not have...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,037.47 firm fixed-price delivery order is for the supply of Cetirizine HCL 1 mg/ml solution, a generic antihistamine medication. The contract has an ultimate completion date of April 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,463.26 firm fixed-price delivery order is for the supply of Cetirizine HCL 1 mg/ml solution, 120 ml, to support military healthcare programs. The award has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $12,205.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Cetirizine HCL 1 mg/ml solution, with a completion date of December 8, 2023. The award has a firm fixed-price pricing type and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This federal contract award, valued at $2,197.91, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of cetirizine hydrochloride 1 mg/mL solution in 120 mL bottles. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November 2026. This IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,001.86 firm-fixed-price contract is for the delivery of Cetirizine Hydrochloride 1 mg/ml solution in 120 ml bottles. There is no set-aside designation, indicating the contract was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract provides for the delivery of Cetirizine HCL 1 mg/ml solution in 473 ml bottles, a pharmaceutical product. The contract has a ceiling value of $3,772.76 and is a Firm Fixed Price Delivery Order, with a completion date of January 4, 2023. The award was made without the use of a set-aside. As a major...
- This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $25,295.68 and an ultimate completion date of September 21, 2023. It is a firm-fixed-price delivery order contract, without any...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Cetirizine HCL 10 mg tablets. The contract has a ceiling value of $10,334.41 and is a Firm Fixed Price Delivery Order, with a period of performance through March 19, 2025. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,214.63 and is for the delivery of Cetirizine HCL 1 mg/ml solution in 120 ml bottles. The contract is a firm fixed-price delivery order with a period of performance through May 17, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN1V6Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Cetirizine HCL 1 mg/ml solution, a prescription medication, with a ceiling value of $4,137.57 and a completion date of April 25, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00, for the delivery of a wide range of pharmaceutical products and medical supplies to support federal healthcare programs, particularly for the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 4/24/23 |